Amyotrophic Lateral Sclerosis Awareness Month.
Fiscal committee
No
Current location
Pending Referral
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates May 2026 as Amyotrophic Lateral Sclerosis (ALS) Awareness Month in California. It recognizes the seriousness of ALS, a progressive and fatal neurodegenerative disease, and the challenges faced by those living with it and their families. The resolution aims to increase public awareness of ALS, support research efforts, and advocate for improved access to treatments and services for individuals affected by this disease.
Key provisions
- Proclaims May 2026 as Amyotrophic Lateral Sclerosis Awareness Month in California.
- Affirms the Legislature’s dedication to ensuring access to effective treatments for ALS.
- Calls for identifying risk factors and causes to prevent new cases of ALS.
- Encourages empowering individuals with ALS to participate fully in life.
- Seeks to reduce the physical, emotional, and financial burdens of living with ALS.
- Promotes ensuring high-quality services and supports for individuals with ALS and their caregivers.
- Commends those working to improve the quality and length of life for ALS patients.
- Recognizes the role of organizations like The ALS Association in research and support.
Who is affected
- Individuals with Amyotrophic Lateral Sclerosis (ALS)
- Families and caregivers of individuals with ALS
- Researchers and healthcare providers
- The ALS Association and related organizations
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours